KEWAUNEE SCIENTIFIC CORP /DE/
For the period ended Apr 30, 2025. Filed Jul 2, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Jul 2, 2025
KEQU$33.61-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
The following documents are filed or incorporated by reference as part of this Annual Report:
| Page | ||
|---|---|---|
| (a)(1) · Consolidated Financial Statements | ||
| Report of Independent Registered Public Accounting Firm | 22 | |
| Consolidated Statements of Operations—Years ended April 30, 2025 and 2024 | 24 | |
| Consolidated Statements of Comprehensive Income—Years ended April 30, 2025 and 2024 | 25 | |
| Consolidated Statements of Stockholders' Equity—Years ended April 30, 2025 and 2024 | 26 | |
| Consolidated Balance Sheets—April 30, 2025 and 2024 | 27 | |
| Consolidated Statements of Cash Flows—Years ended April 30, 2025 and 2024 | 28 | |
| Notes to Consolidated Financial Statements | 30 | |
| (a)(2) | Consolidated Financial Statement Schedules | |
| Financial statement schedules have been omitted because the information required has been separately disclosed in the consolidated financial statements or related notes. | ||
| (a)(3) | Exhibits | |
| Exhibits required by Item 601 of Regulation S-K are listed in the Exhibit Index, which is attached hereto at pages 58 through 60 and which is incorporated herein by reference. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.